Table 4.
Per-patient APCs in patients with diabetes with nonobstructive angiographic stenoses versus patients without diabetes with obstructive angiographic stenoses
| Without diabetes, obstructive | With diabetes, nonobstructive | ||
|---|---|---|---|
| Variable | (n = 118) | (n = 38) | P value |
| PV (mm3) | 545.0 (286.6, 866.2) | 471.6 (291.3, 717.0) | 0.1581 |
| LD-NCP (mm3) | 9.7 (3.7, 18.6) | 8.1 (2.6, 14.2) | 0.1575** |
| NCP (mm3) | 333.4 (178.0, 575.1) | 280.1 (135.5, 406.6) | 0.0921 |
| CP (mm3) | 130.5 (45.7, 355.2) | 126.6 (12.9, 252.3) | 0.2189** |
| % PAV | 17.4 (10.9, 27.0) | 14.6 (8.9, 23.9) | 0.2453 |
| % PAV LD-NCP | 0.32 (0.12, 0.61) | 0.27 (0.11, 0.47) | 0.2729 |
| % PAV NCP | 11.5 (7.3, 16.7) | 10.2 (6.6, 13.2) | 0.1154 |
| % PAV CP | 4.0 (1.6, 12.1) | 3.2 (0.3, 11.0) | 0.3143** |
| Remodeling index | 1.30 (1.20, 1.50) | 1.30 (1.20, 1.40) | 0.3396 |
| PR | 104 (88.1) | 29 (76.3) | 0.0465 |
| HRP | 92 (78.0) | 28 (73.7) | 0.5858 |
| Max lesion length (mm) | 28.8 (17.0, 41.5) | 28.4 (15.0, 43.8) | 0.6994 |
| Max stenosis | 75 (62.0, 100) | 48.0 (39.0, 61.0) | <0.0001 |
| Max CAD-RADS*, mean (SD) | 3.9 (1.0) | 2.6 (0.9) | |
| No. of diseased vessels (QCA) | |||
| 0 | 0 | 38 (100) | — |
| 1 | 74 (62.7) | ||
| 2 | 30 (25.4) | ||
| 3 (or LM) | 14 (11.9) | ||
| No. of diseased vessels (CCTA) | |||
| 0 | 7 (5.9) | 21 (55.3) | <0.0001 |
| 1 | 57 (48.3) | 10 (26.3) | |
| 2 | 29 (24.6) | 6 (15.8) | |
| 3 (or LM) | 25 (21.2) | 1 (2.6) |
Data are presented as median (quartile 1, quartile 2) or as n (%), unless indicated otherwise as mean (SD). LM, left main coronary artery.
*
CAD-RADS stenosis defined as 0 = 0%; 1 = 1–25%; 2 = 26–49%; 3 = 50–69%; 4 = 70–99%; 5 = 100%.
**
Inadequate power to distinguish a difference.